Evidence map›Paper›PMID 25972271›Full record

ArticleHealth and quality of life outcomes2015

Quality of life and its association with direct medical costs for COPD in urban China.

Minmin Wu, Qi Zhao, Yue Chen, Chaowei Fu, Biao Xu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health and quality of life outcomes, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. The quality of life in Chinese population with chronic non-communicable diseases according to EQ-5D-3L: a systematic review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2018
    Pooled it
  3. A Systematic Literature Review of the Humanistic Burden of COPD.International journal of chronic obstructive pulmonary disease
    Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Minmin WuSchool of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, 200032, China. mmwu@fudan.edu.cn.
Qi ZhaoSchool of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, 200032, China. zhaoqi@shmu.edu.cn.
Yue ChenFaculty of Medicine, University of Ottawa, Ottawa, ON, Canada. Yue.Chen@uottawa.ca.
Chaowei FuSchool of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, 200032, China. cwfu@shmu.edu.cn.
Biao XuSchool of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, 200032, China. bxu@shmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic obstructive pulmonary disease (COPD) is one of the leading causes of death worldwide. Few studies have focused on the quality of life (QoL) associated medical costs for COPD in China.

methodsA cross-sectional survey of 678 COPD patients was conducted in four major cities (Beijing, Shanghai, Guangzhou and Chengdu), China, in 2011. Data on socio-demographic information, health conditions and medical costs were collected through a face-to-face interview combined with medical record searching. The EuroQol (EQ-5D) health questionnaire was applied to assess the QoL of COPD patients.

resultsAmong 678 patients with COPD, nearly 40% had difficulties in mobility, usual activities and pain/discomfort, one third had various degrees of anxiety/depression, and one fifth had difficulties in self-care. The COPD patients had a median utility score of 0.768 and a median visual analog scale score of 70. The degree of difficulties in any dimensions significantly increased, and utility and health scores decreased with severity of the disease. Age, gender and disease severity were significantly associated with the quality of life after taking other covariates into consideration. Poorer QoL was a significant indicator of higher direct medical costs for COPD patients.

conclusionImpaired quality of life was significantly linked to increased medical costs for COPD patients and could be an important measure for policy- and decision-making in COPD care.

Indexed as

Quality of LifeSickness Impact ProfileAgedAged, 80 and overBeijingChinaCost of IllnessCross-Sectional StudiesFemaleHumansMaleMiddle AgedPulmonary Disease, Chronic ObstructiveSelf CareSocioeconomic FactorsSurveys and Questionnaires

Identifiers

PMID25972271
PMCPMC4429937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.